Real-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis
Authors:
- Saad Arsalan WastiSWSaad Arsalan Wasti
- Saima GillSGSaima Gill
- Alina JamshedAJAlina Jamshed
- Meeram NoorMNMeeram Noor
- Nafeesa GillNGNafeesa Gill
- Areesha WastiAWAreesha Wasti
- Sahla WaqasSWSahla Waqas
- Tayyaba QayyumTQTayyaba Qayyum
- Yousef JosephYJYousef Joseph
- Fahad AminFAFahad Amin
- Khadija MohibKMKhadija Mohib
- Arbab KhalidAKArbab Khalid
Open Access
- 3 October 2026
- journal article
- review article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapyBreast Cancer Research and Treatment, 2025
- Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 studyThe Breast, 2025
- Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancerDiscover Oncology, 2024
- LBA18 Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 studyAnnals of Oncology, 2023
- 169P Neoadjuvant pembrolizumab + chemotherapy followed by adjuvant pembrolizumab for treatment of high-risk, early-stage triple-negative breast cancer: A network meta-analysisAnnals of Oncology, 2022
- Use of the GRADE approach in systematic reviews and guidelinesBritish Journal of Anaesthesia, 2019
- From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not WorkDrugs - Real World Outcomes, 2019
- Data Analysis Using R Programming2018
- Random effects meta‐analysis: Coverage performance of 95% confidence and prediction intervals following REML estimationStatistics in Medicine, 2016
- Triple negative breast cancer: unmet medical needsBreast Cancer Research and Treatment, 2010